ESTRELLA IMMUNOPHARMA, INC. (ESLA) Gross margin
ESTRELLA IMMUNOPHARMA, INC. (ESLA) gross margin by fiscal year — reported gross profit divided by reported revenue.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to ESLASource: SEC XBRL filings · For reference only · Not investment advice
More ESLA financial trends
ESLA RevenueESLA Net incomeESLA Net marginESLA Gross profitESLA Operating incomeESLA Operating marginESLA Operating cash flowESLA Free cash flowESLA Capital expendituresESLA Return on equityESLA Stock buybacksESLA Dividends paidESLA Total assetsESLA Total liabilitiesESLA Shareholders’ equityESLA overview →